Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease.
Costa TEM, Lauar JC, Innecchi MLR, Coelho VA, Moysés RMA, Elias RM.
Int Urol Nephrol. 2022 Sep;54(9):2255-2261. doi: 10.1007/s11255-022-03116-5. Epub 2022 Jan 31.
Drug-induced hyperuricaemia and gout.
Ben Salem C, Slim R, Fathallah N, Hmouda H.
Rheumatology (Oxford). 2017 May 1;56(5):679-688. doi: 10.1093/rheumatology/kew293.
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators.
Am J Kidney Dis. 2018 Dec;72(6):798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1.
Hyperuricemia and gout.
Lioté F.
Curr Rheumatol Rep. 2003 Jun;5(3):227-34. doi: 10.1007/s11926-003-0072-y.
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N.
N Engl J Med. 2005 Dec 8;353(23):2450-61. doi: 10.1056/NEJMoa050373.
[Pathophysiology and treatment of secondary hyperuricemia].
Tsutani H.
Nihon Rinsho. 2008 Apr;66(4):699-704.
Thiazide and loop diuretics.
Sica DA, Carter B, Cushman W, Hamm L.
J Clin Hypertens (Greenwich). 2011 Sep;13(9):639-43. doi: 10.1111/j.1751-7176.2011.00512.x. Epub 2011 Jul 27.
[Asymptomatic hyperuricemia: primary? secondary? when to treat?].
García Puig J.
Med Clin (Barc). 1993 Jan 23;100(3):101-3.
Editorial on the Paper "The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis" by Butler, Alghoubayshi and Roman.
Zahir FR.
J Pers Med. 2022 Aug 19;12(8):1331. doi: 10.3390/jpm12081331.
[Hyperuricemia and gout].
Gröbner W.
Dtsch Med Wochenschr. 2015 Oct;140(21):1615-26. doi: 10.1055/s-0041-104420. Epub 2015 Oct 21.
